Rheumatology Information Service Europe
Kineret FAQs: Contraindications, Precautions, and Special Warnings
« Go back to Overview

Q33: What are the contraindications to Kineret® therapy and the special warnings and precautions for use?
» Read answer

Q34: What are the Kineret® dosing recommendations in patients with impaired renal function?
» Read answer

Q35: Is the administration of Kineret® recommended in paediatric patients?
» Read answer

Q36: Can Kineret® be used in geriatric patients?
» Read answer

Q37: Should Kineret® be used in pregnant or breast-feeding women?
» Read answer

Q38: Is it safe to vaccinate patients who are being treated with Kineret®?
» Read answer

Q39: Should Kineret® be stopped prior to surgery?
» Read answer

Q40: Can Kineret® be used in combination with tumour necrosis factor (TNF) inhibitors?
» Read answer

Q41: Is it possible to administer Kineret® intra-articularly?
» Read answer



« Go back to Overview

Downloads

Kineret® Summary of Product Characteristics
» View document
» Download document


© 2008 Biovitrum AB (publ). All rights reserved.
This is a European website containing information about Kineret® (anakinra) and is intended for healthcare professionals within the European Union. The information on this site is not country-specific and may contain product-related information that is outside the approved product data sheet in the country in which you are located.
» Privacy Policy     » Terms of Use     » Contact Us